The Catalyst

Most Recent Posts


[caption id="attachment_4244" align="alignleft" width="150" caption="Asad Zaidi/Courtesy of UNICEF Pakistan"][/caption]

10.23.12 | By Preet Bilinski

The third-leading cause of death in the U.S. is not nearly as recognizable as it should be, even to those who suffer from the condition.


I've been a contributor on our very own blog, the Catalyst, for a year now. I try my best to write interesting blog posts that pertain to the incredible work biopharmaceutical scientists do to help improve patient care in the U.S. and around the world.


At the heart of any productive relationship or venture is trust. In the biopharmaceutical sector, the integrity of our products, our research - and ultimately the faith that physicians and patients have in medicines - requires trust. And it's something that must be earned.

10.18.12 | By Chip Davis

I was encouraged Tuesday night during the Presidential debate to hear both candidates say they want to create high-wage, high-skill American jobs in what is called "advanced manufacturing." The biopharmaceutical industry represents just the kind of jobs the President wants and o

10.10.12 | By Preet Bilinski

Michael J. Fitzpatrick is executive director at NAMI, the National Alliance on Mental Illness.

10.09.12 | By Preet Bilinski

The stigma that surrounds mental illness remains a challenge. It can be difficult even for patients to accept and understand their diagnosis. So this week we join others in the mental health community participating in Mental Illness Awareness Week.


This morning, British scientist John Gurdon shared one of two Nobel Prizes awarded this year in physiology and medicine. Dr.


In this month's issue of Psychology Today, there was a good read about the psychological impact of having a rare disease, 'The Loneliest Fight', profiling four patients' experience with very differe


Medicare Today has released its 2012 beneficiary satisfaction survey results today and to put it simply, seniors love Medicare Part D.


Over a decade ago, when SARS (Severe Acute Respiratory Syndrome) was first detected in China, it took significant time to identify the virus and to understand how the disease spread among affected populations.